BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/25/2025 11:24:06 AM | Browse: 61 | Download: 32
 |
Received |
|
2025-05-18 04:42 |
|
Peer-Review Started |
|
2025-05-18 04:43 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-05-28 21:22 |
|
Revised |
|
2025-06-10 22:52 |
|
Second Decision |
|
2025-09-09 02:41 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-09-09 09:29 |
|
Articles in Press |
|
2025-09-09 09:29 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-09-17 06:36 |
|
Publish the Manuscript Online |
|
2025-09-25 11:24 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Noninvasive prediction of clinically significant portal hypertension in metabolic dysfunction-associated steatotic liver disease compared to other chronic liver diseases
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Muaaz Masood and Ragesh Babu Thandassery |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ragesh Babu Thandassery, Associate Professor, DM, MD, Division of Gastroenterology, Department of Internal Medicine, University of Arkansas for Medical Sciences, 4300 W 7th Street, Little Rock, AR 72205, United States. doc.ragesh@gmail.com |
| Key Words |
Clinically significant portal hypertension; Compensated advanced chronic liver disease; Metabolic dysfunction-associated steatotic liver disease; Metabolic dysfunction-associated steatohepatitis; Non-invasive tests |
| Core Tip |
The management of chronic liver disease has increasingly become noninvasive. The Baveno VII consensus recommends a noninvasive strategy to diagnose compensated advanced chronic liver disease (cACLD) and clinically significant portal hypertension (CSPH). However, the diagnostic accuracy of the Baveno criteria for predicting CSPH among patients with metabolic dysfunction-associated steatotic liver disease (MASLD) is not well-established. This is pertinent as MASLD has become the leading cause of cACLD in the United States. In this mini-review, we discuss the diagnostic performance of the Baveno criteria and other noninvasive scores for predicting CSPH in patients with MASLD and non-MASLD related cACLD. |
| Publish Date |
2025-09-25 11:24 |
| Citation |
<p>Masood M, Thandassery RB. Noninvasive prediction of clinically significant portal hypertension in metabolic dysfunction-associated steatotic liver disease compared to other chronic liver diseases. <i>World J Hepatol</i> 2025; 17(9): 109691</p> |
| URL |
https://www.wjgnet.com/1948-5182/full/v17/i9/109691.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v17.i9.109691 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
